In another study, Jiang et al. compared SESN2 levels in patients with severe obstructive sleep apnea (OSA) before and after four weeks of nasal continuous positive airway pressure (nCPAP) treatment. This evidence concerns the gene SESN2 and obstructive sleep apnea syndrome.